Lotus Pharmaceuticals, Inc. (LTUS)

Market Cap	10.74M -65.2%
Revenue (ttm)	71.39M +4.3%
Net Income	1.72M -91.6%
EPS	0.06 -92.0%
Shares Out	2.64B
PE Ratio	0.07
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,660
Average Volume	27,859
Open	0.0041
Previous Close	0.0054
Day's Range	0.0041 - 0.0041
52-Week Range	0.0025 - 0.0111
Beta	-2.01
RSI	49.56
Earnings Date	n/a

About Lotus Pharmaceuticals

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People’s Republic of China. The company was formerly known as S.E. Asia Trading, Inc. and changed its name to Lotus Pharmaceuticals, Inc. in December 2006. Lotus Pharmaceuticals, Inc. is based in Irvine, California.

• Industry: Shell Companies
• Sector: Financials
• CEO: Zhong Yi Liu
• Employees: 533
• Stock Exchange: OTCMKTS
• Ticker Symbol: LTUS